|
|||||
|
|
Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial |
|
| Authors: | M. J. Davies MD D. Russell‐Jones MD J.‐L. Selam MD T. S. Bailey MD Z. Kerényi MD J. Luo PhD J. Bue‐Valleskey MS T. Iványi MD M. L. Hartman MD J. G. Jacobson PhD S. J. Jacober DO for the IMAGINE Study Investigators |
| Affiliation: | 1. Department of Health Sciences, Diabetes Research Centre, University of Leicester, Leicester, UK;2. Department of Endocrinology and Diabetes, Royal Surrey County Hospital, Guildford, UK;3. Diabetes Research Center, Tustin, California;4. AMCR Institute, Escondido, California;5. Csepel Health Service, Budapest, Hungary;6. Eli Lilly and Company, Indianapolis, Indiana;7. Eli Lilly and Company, Budapest, Hungary |
| Abstract: | |
| Keywords: | basal insulin peglispro BIL insulin‐naï ve insulin therapy type 2 diabetes |